BONESUPPORT Receives FDA Approval to Initiate IDE Clinical Study

BONESUPPORT received FDA approval to launch an Investigational Device Exemption study of CERAMENT G in the treament of open diaphyseal tibial fractures, slated to start by the end of 2016.

The randomized, multicenter, controlled, 230-patient FORTIFY trial will evaluate safety and efficacy of the injectable gentamicin antibiotic-eluting bone...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0